Gregory T. Lucier
Chairman of the Board and Chief Executive Officer
Gregory T. Lucier has served as our Chairman and Chief Executive Officer since May 2015. He has served as a member of the NuVasive Board of Directors since December 2013. From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries. Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence and applied his more than 25 years of strategic management experience to deliver industry-leading operating margins, double-digit compounded annual growth in earnings per share and significant free cash flow. Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems. He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School. In addition to serving on the Board of NuVasive, Mr. Lucier serves as the Board Chairman for Sanford Burnham Medical Research Institute, is a member of the Catalent, Inc. Board of Directors and is a former director of CareFusion Corporation, now part of Becton, Dickinson & Co.
Jack R. Blair
Jack R. Blair has served as a member of our Board of Directors since August 2001. During his 18-year career, Mr. Blair served in various capacities with Smith & Nephew PLC and Richards Medical Company, which was acquired by Smith & Nephew in 1986. Most recently, he was Group President of Smith & Nephew’s North and South American and Japanese operations (1986-1998) and held the position of President of Richards Medical Company (1982-1986). Until November 2007, when the company was sold, Mr. Blair served as Chairman of the Board of Directors of DJO Inc., an orthopaedic medical device company. He also serves as a director of a privately held orthopaedic company, a privately held tissue repair company, and a privately held specialty chemicals company. Mr. Blair holds a B.A. in Government from Miami University and an M.B.A. from the University of California, Los Angeles.
Lesley H. Howe
Lesley H. Howe has served as a member of our Board of Directors since February 2004. Mr. Howe has more than 40 years of experience in accounting, finance, and business management within a variety of industries. From December 2001 until May 2007, he served as Chief Executive Officer of Consumer Networks LLC, a San Diego-based Internet marketing and promotions company. During Mr. Howe’s 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, he was an audit partner for 23 years and an area managing partner/managing partner of the Los Angeles office of KPMG for three years. While there Mr. Howe worked as an independent financial and business consultant for three years, advising clients on acquisition due diligence and negotiation strategies, as well as financing strategies. Mr. Howe currently serves on the Board of Directors of Jamba Inc., the leading retailer of quality blended fruit beverages. Mr. Howe received a B.S. in Business Administration from the University of Arkansas.
Peter C. Farrell, Ph.D., AM
Peter C. Farrell, Ph.D., AM has served as a member of our Board of Directors since January 2005. Dr. Farrell was founding Chairman and Chief Executive Officer of ResMed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing. He held those positions from 1989 until 2007. Dr. Farrell holds bachelor’s and master’s degrees in Chemical Engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Washington, Seattle, and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.
Vickie L. Capps
Vickie L. Capps has served as a member of our Board of Directors since June 2015. From July 2002 to December 2013, Ms. Capps served as the Chief Financial Officer of DJO Global, Inc. Prior to joining DJO Global, she served as the Chief Financial Officer of several other public and private companies. Earlier in her career, she served as a senior audit and accounting professional at Ernst & Young LLP. Ms. Capps is a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare investment firm, and serves on the board of its portfolio company, Enclara Pharmacia. She also serves on the board of directors and as chair of the audit committees of RF Surgical Systems, Inc., Otonomy, Inc. and Connecture, Inc. Ms. Capps is a California Certified Public Accountant and was recognized as CFO of the Year by the San Diego Business Journal in 2009 and 2010. She earned a bachelor’s degree in business administration/accounting from San Diego State University.
Daniel J. Wolterman
Daniel J. Wolterman has served as a member of our Board of Directors since July 2015. Mr. Wolterman has been President and CEO of Memorial Hermann Health System since 2002. He has more than 30 years of experience in the healthcare industry and a long history of community involvement. He serves on the Joint Commission’s Center for Transforming Healthcare Leadership Advisory Council, and he continues to serve on the Greater Houston Partnership and Voluntary Hospitals of America boards of directors. He previously served on the board of directors of Volcano Corporation until the completion of its acquisition by Royal Philips in February of this year. Mr. Wolterman is also an Adjunct Professor at The University of Texas School of Public Health. Mr. Wolterman earned a B.S. degree in Business Administration in 1979 and a M.B.A. in Finance in 1980 from the University of Cincinnati and a Master’s Degree in Healthcare Administration from Xavier University in 1982.
Leslie V, Norwalk, Esq.
Leslie V Norwalk, Esq., has served as a member of our Board of Directors since May 2014. Ms. Norwalk serves as a Strategic Advisor and Strategic Counsel to Epstein Becker & Green, P.C., EBG Advisors, Inc., and National Health Advisors. Ms. Norwalk is an Operating Partner at Enhanced Equity Fund, L.P. She serves as an Advisor to Warburg Pincus LLC, and Ferrer Freeman & Company. Previously, Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services, where she managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit. Prior to serving the Bush Administration, Ms. Norwalk practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative. In addition to NuVasive, Ms. Norwalk serves as a Director of the following organizations: Primary Care Associates Medical Group, Inc., ikaSystems Corporation, Press Ganey Associates, and Abode Healthcare. Ms. Norwalk also serves as Member of International Advisory Council at APCO Worldwide Inc. She earned a J.D. degree from the George Mason University School of Law and a bachelor’s degree, cum laude, in Economics and International Relations from Wellesley College.